117 related articles for article (PubMed ID: 4741031)
1. Modification by methyltyrosine methylester (H 44-68) of the amphetamine-induced toxicity and brain catecholamine changes in developing mice.
Alhava E
Acta Pharmacol Toxicol (Copenh); 1973; 32(1):119-28. PubMed ID: 4741031
[No Abstract] [Full Text] [Related]
2. Modification by L-DOPA methylester (H 19-61) of amphetamine-induced brain catecholamine changes, thermal responses and toxicity in developing mice.
Alhava E
Acta Pharmacol Toxicol (Copenh); 1973; 33(5):330-47. PubMed ID: 4801079
[No Abstract] [Full Text] [Related]
3. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
Dominic JA; Moore KE
Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
[No Abstract] [Full Text] [Related]
4. Stimulus-dependent antagonism of the alpha-methyltyrosine-induced lowering of brain catecholamines by (+)-amphetamine in intact mice.
Welch BL; Welch AS
J Pharm Pharmacol; 1967 Dec; 19(12):841-3. PubMed ID: 4384230
[No Abstract] [Full Text] [Related]
5. Compartmentation of dopamine in rat striatum.
Doteuchi M; Wang C; Costa E
Mol Pharmacol; 1974 Mar; 10(2):225-34. PubMed ID: 4152816
[No Abstract] [Full Text] [Related]
6. Nicotine hypothermia and brain nicotine and catecholamine levels in the mouse.
Mansner R; Alhava E; Klinge E
Med Biol; 1974 Dec; 52(6):390-8. PubMed ID: 4444360
[No Abstract] [Full Text] [Related]
7. Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain.
Hutchins DA; Rogers KJ
Br J Pharmacol; 1973 May; 48(1):19-29. PubMed ID: 4269287
[TBL] [Abstract][Full Text] [Related]
8. Reversal of alpha-methyltyrosine-induced behavioural depression with dihydroxyphenylalanine and amphetamine.
Moore KE; Rech RH
J Pharm Pharmacol; 1967 Jun; 19(6):405-7. PubMed ID: 4382374
[No Abstract] [Full Text] [Related]
9. Social environment and brain biogenic amine metabolism in rats.
Stolk JM; Conner RL; Barchas JD
J Comp Physiol Psychol; 1974 Aug; 87(2):203-7. PubMed ID: 4279254
[No Abstract] [Full Text] [Related]
10. Different central mediation of the stimulant effects of amphetamine and its p-chloro analogue.
Frey HH; Magnussen MP
Biochem Pharmacol; 1968 Jul; 17(7):1299-307. PubMed ID: 5659777
[No Abstract] [Full Text] [Related]
11. Supersensitivity to the central stimulant actions of adrenergic drugs following discontinuation of a chronic diet of alpha-methyltyrosine.
Dominic JA; Moore KE
Psychopharmacologia; 1969; 15(2):96-101. PubMed ID: 4390822
[No Abstract] [Full Text] [Related]
12. Modification by disulfiram or methyltyrosine methylester (H 44-68) of abstinence symptoms in morphine-tolerant rats.
Mattila MJ; Alhava E; Mansner R
Arzneimittelforschung; 1968 Sep; 18(9):1163-6. PubMed ID: 5755932
[No Abstract] [Full Text] [Related]
13. Age and brain catecholamine content as factors influencing amphetamine toxicity in mice.
Alhava E; Klinge E
Acta Pharmacol Toxicol (Copenh); 1972; 31(5):401-11. PubMed ID: 4678823
[No Abstract] [Full Text] [Related]
14. Effect of alpha-methyltyrosine on operant behavior and brain catecholamine levels.
Schoenfeld RI; Seiden LS
J Pharmacol Exp Ther; 1969 Jun; 167(2):319-27. PubMed ID: 5787869
[No Abstract] [Full Text] [Related]
15. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
Beuthin FC; Miya TS; Blake DE; Bousquet WF
J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
[No Abstract] [Full Text] [Related]
16. Specific inhibition by -methyltyrosine of amphetamine-induced amine release from brain.
Enna SJ; Dorris RL; Shore PA
J Pharmacol Exp Ther; 1973 Mar; 184(3):576-82. PubMed ID: 4687221
[No Abstract] [Full Text] [Related]
17. Pharmacologic properties and mechanism of action of amfonelic acid.
Aceto MD; Botton I; Martin R; Levitt M; Bentley HC; Speight PT
Eur J Pharmacol; 1970; 10(3):344-54. PubMed ID: 4393073
[No Abstract] [Full Text] [Related]
18. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
Khalsa JH; Davis WM
J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
[No Abstract] [Full Text] [Related]
19. Letter: Dual mechanism of amphetamine toxicity in mice: relationship to brain catecholamines.
Littleton JM
Acta Pharmacol Toxicol (Copenh); 1974 Jan; 34(1):92-6. PubMed ID: 4406562
[No Abstract] [Full Text] [Related]
20. Neurochemical effects of imipramine and amphetamine in aggressive mouse-killing (muricidal) rats.
Salama AI; Goldberg ME
Biochem Pharmacol; 1970 Jun; 19(6):2023-32. PubMed ID: 5535188
[No Abstract] [Full Text] [Related]
[Next] [New Search]
